Pharma IQ Members

Quality Management
Contributor: Kate Torchilin Ph.D.
Posted: 28/04/2016
default profile icon
Biomarkers are an essential part of such a translational effort and are critical to understanding human disease. Human biospecimens can provide a bridge between the early discovery and molecular mechanism of the disease and the clinical utility. Commonly, human biospecimens are used to: Full Article »
Contributor: Chanice Henry
Posted: 05/04/2016
Miss Chanice Henry
Pharma IQ zooms through the latest predicted trends for the compound and biological sample management industries. The video explores investment levels, team sizes, top challenges and areas for growth. Full Video »
Contributor: Pharma IQ
Posted: 04/10/2010
In this interview Jos van den Heuvel, Director of External Manufacturing at Janssen Pharmaceutica NV, Johnson & Johnson, speaks to Rebecca Maschke from Pharma IQ, about supplier integration and the advantages of establishing a data network collaboration. Full Podcast »
Contributor: Jon Wetzel
Posted: 31/08/2011
Jon Wetzel
From a high level perspective a Quality Management System (QMS) is great but to the lab workers it’s more like a pile of “red tape” that stops them from doing or improving their work. Here’s what you can do to put the “Quality” back into your QMS. Full Column »
Contributor: Chanice Henry
Posted: 21/06/2016
The transition from paper to electronic Trial Master File (TMF) system, is a significant task, which is further complicated with the varying views and opinions complicating the route to standardisation. This is partially solved by the new directives under construction alongside the EMA’s updated information providing giving insight into inspector’s reviewing behaviours and what has been examined as of late for eTMFs. These much needed points of clarification help inform pharma and biotech companies on how to best create and maintain an eTMF system. Full Whitepaper »